Rectal cancer, particularly in its advanced stages, can be challenging to treat due to its tendency to spread within the abdominal cavity. However, medical advancements have ushered in promising techniques that offer new hope. One such cutting-edge approach is HIPEC (Hyperthermic Intraperitoneal Chemotherapy). In this article, Dr. Suvadip Chakrabarti, a renowned robotic onco surgeon in Kolkata, explains how HIPEC is transforming rectal cancer outcomes and why it’s considered a breakthrough in surgical oncology.
What is HIPEC?
HIPEC is an innovative procedure that combines cytoreductive surgery (CRS) with heated chemotherapy delivered directly into the abdominal cavity. After surgically removing visible tumors, a heated chemotherapy solution is circulated in the peritoneal cavity for 60 to 90 minutes. The goal is to destroy any remaining microscopic cancer cells that traditional surgery or systemic chemotherapy might miss.
This targeted approach enhances the effectiveness of treatment while minimizing side effects compared to conventional intravenous chemotherapy.
When is HIPEC Used for Rectal Cancer?
While HIPEC is more commonly associated with cancers like ovarian or peritoneal mesothelioma, it has shown considerable success in cases of advanced or recurrent rectal cancer where the disease has spread to the peritoneum. In such scenarios, conventional treatment options might not offer optimal results.
Dr. Suvadip Chakrabarti emphasizes that patients with peritoneal carcinomatosis from colorectal origin often benefit the most from this combination approach, particularly when they are carefully selected based on imaging, diagnostic laparoscopy, and overall health condition.
Benefits of HIPEC in Rectal Cancer Treatment
- Targeted Therapy: The heated chemotherapy is directly applied to the cancerous area, increasing drug absorption by tumor cells.
- Reduced Systemic Toxicity: Since the drugs aren’t circulated throughout the entire body, patients experience fewer side effects.
- Improved Survival Rates: Studies suggest improved progression-free survival in eligible patients who undergo HIPEC with CRS.
- Enhanced Quality of Life: For selected patients, HIPEC offers a chance at longer survival and reduced disease burden.
The Role of Robotic Surgery in HIPEC
As one of the few specialists trained in both robotic and laparoscopic cancer surgery, Dr. Suvadip Chakrabarti integrates robot-assisted techniques to improve surgical precision during cytoreductive procedures.
Robotic surgery allows for:
- Better visualization of the abdominal cavity.
- Reduced surgical trauma.
- Faster recovery times.
- Greater accuracy in tumor removal.
Being a leading Robotic onco surgeon in Kolkata, Dr. Chakrabarti brings advanced technology and compassionate care together to ensure optimal results for complex cancer cases.
Why Choose Dr. Suvadip Chakrabarti for HIPEC?
- Expertise in Advanced Surgical Oncology: Trained at premier institutions, Dr. Chakrabarti specializes in complex GI and peritoneal surface malignancies.
- Pioneer in Robotic Oncosurgery: He is among the few surgeons in Kolkata to offer robotic surgery for cancers of the colon, rectum, stomach, and pancreas.
- Comprehensive Cancer Care: From diagnosis to post-operative care, Dr. Chakrabarti offers a multidisciplinary approach to treatment.
- Personalized Patient Focus: Each treatment plan is tailored to the patient's unique condition, maximizing effectiveness and minimizing risk.
Final Thoughts
HIPEC represents a significant advancement in the treatment of advanced rectal cancer, especially when combined with state-of-the-art surgical techniques. With increasing evidence supporting its use and the availability of skilled specialists like Dr. Suvadip Chakrabarti, patients now have access to world-class treatment right here in Kolkata.
If you or your loved one has been diagnosed with advanced colorectal cancer or peritoneal carcinomatosis, consult an experienced Robotic onco surgeon to explore if HIPEC is the right option.
